New cholinesterase inhibitors for Alzheimer’s disease: Structure Activity Studies (SARs) and molecular docking of isoquinolone and azepanone derivatives-Reference-Cited by-同舟云学术

New cholinesterase inhibitors for Alzheimer’s disease: Structure Activity Studies (SARs) and molecular docking of isoquinolone and azepanone derivatives

Published:2016-08 Issue: Volume:67 Page:1-8
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Bacalhau Patrícia,San Juan Amor A.,Marques Carolina S.,Peixoto Daniela,Goth Albertino,Guarda Cátia,Silva Mara,Arantes Sílvia,Caldeira A. Teresa,Martins Rosário,Burke Anthony J.

Funder

INMOLFARM - Molecular Innovation and Drug Discovery

Foundation for Science and Technology

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference49 articles.

1. “It Ain’t Over ’til It’s Over”a—The Search for Treatments and Cures for Alzheimer’s Disease

2. New Perspectives on Alzheimer's Disease

3. The cholinergic system in Alzheimer's disease

4. SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in screening assays for identifying cholinesterase ligands;TrAC Trends in Analytical Chemistry;2023-11

2. Docking-Based Prediction of Peptide Binding to MHC Proteins;Computational Vaccine Design;2023

3. Tetrahydroazepines with an annulated five-membered heteroaromatic ring;Chemistry of Heterocyclic Compounds;2022-11

4. In silico Study of Coumarins Derivatives With Potential Use in Systemic Diseases;Biointerface Research in Applied Chemistry;2022-06-06

5. Synthesis, in vitro and docking studies of 2-substituted 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine-4(3H)-one derivatives as agents for the treatment of Alzheimer's disease;Chimica Techno Acta;2022-04-26